Thomas J. Falk - 09 May 2025 Form 3 Insider Report for AbbVie Inc. (ABBV)

Role
Director
Signature
/s/ T.O. Odutayo, Attorney-in-Fact for Thomas J. Falk
Issuer symbol
ABBV
Transactions as of
09 May 2025
Transactions value $
$0
Form type
3
Filing time
13 May 2025, 17:04:57
Previous filing
19 Feb 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
FALK THOMAS J Director 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO /s/ T.O. Odutayo, Attorney-in-Fact for Thomas J. Falk 13 May 2025 0001222890

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ABBV Common Stock, $0.01 par value 1.2K 09 May 2025 Direct F1
holding ABBV Common Stock, $0.01 par value 3K 09 May 2025 By limited partnership F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
F2 The securities are owned by a limited partnership that is jointly controlled by the reporting person and his spouse. The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.